ROLE OF T LYMPHOCYTES IN AIRWAY HYPERRESPONSIVENESS
ROLE OF T LYMPHOCYTES IN AIRWAY HYPERRESPONSIVENESS
批准号:
6327724
负责人:
ERWIN William GELFAND
金额:
$28.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2001-06-30
关键词:
T cell receptor T lymphocyte active immunization allergens athymic mouse cell adhesion molecules cellular immunity disease /disorder model eosinophil humoral immunity immunoglobulin E inflammation interferon gamma interleukin 4 interleukin 5 laboratory mouse leukocyte activation /transformation passive immunization respiratory hypersensitivity tissue /cell culture
中文摘要
呼吸道炎症目前被认为是主要的致病因素
导致呼吸道高反应性的机制。虽然很多人
不同的细胞类型及其产物有助于
致敏患者的呼吸道炎症反应或
对于动物来说,T淋巴细胞似乎起着关键作用。T
淋巴细胞调节IgE的产生并分泌大量的
促炎症细胞因子,其中之一,IL-5,控制嗜酸性粒细胞
生产、激活和生存。这样做的目的是
建议是描述体液和细胞中介的作用
免疫在呼吸道高反应性发展中的作用vbl.使用
通过呼吸道的过敏原致敏的小鼠模型,我们有
确定了以下三个基本组件的融合
气道反应性改变的发展,通过抗原攻击
呼吸道,产生(一致的)抗原特异性IgE,
T细胞的抗原依赖性激活(包括CD4+和
CD8+)导致IL-5产生和嗜酸性粒细胞聚集
肺部。利用免疫学和遗传操作,我们现在将
明确抗原特异性免疫球蛋白E在扩增
T细胞的招募、扩增和分化,可能是通过
与B细胞表面CD23结合。我们将描述这个角色的特点
单个T细胞亚群在改变的发展中发挥作用
在裸鼠体内过继转移T细胞引起的呼吸道反应,
分析这些细胞的细胞因子谱和归巢反应
在呼吸道挑战之后。利用IL-5和IL-4缺乏
小鼠,我们将确定这些细胞因子在
嗜酸性炎症的发展。基于先前的研究
雾化吸入干扰素-γ调节这些细胞因子的有效性
抗原特异性反应,我们将定义这一点如何重要
调节性细胞因子改变B和T细胞功能以使其正常化
主要或继发性变应原引起的呼吸道反应性
挑战。这些研究将确定重要的免疫学
对获得改变的呼吸道反应性的贡献,
为更好地了解该病的发病机制铺平了道路
哮喘和新的治疗选择的发展。
英文摘要
Airway inflammation is currently regarded as the major pathogenetic
mechanism leading to airway hyperresponsiveness. Although many
different cell types and their products contribute to the
inflammatory reaction in the airways of sensitized patients or
animals, the T lymphocyte appears to play a pivotal role. T
lymphocytes regulate IgE production and secrete a number of
proinflammatory cytokines, one of which, IL-5, controls eosinophil
production, activation and survival. The objectives of this
proposal are to delineate the roles of humoral and cell-mediated
immunity in the development of airway hyperresponsiveness. Using
a murine model of allergen-sensitization via the airways, we have
identified the convergence of three essential components in the
development of altered airway responsiveness, antigen challenge via
the airways, the production of (concordant) antigen-specific IgE,
and the antigen-dependent activation of T cells (both CD4+ and
CD8+) resulting in IL-5 production and eosinophil accumulation in
the lung. Using immunologic and genetic manipulations, we will now
define the role antigen-specific IgE plays in the amplification of
T-cell recruitment, expansion and differentiation, perhaps through
binding to CD23 on B cells. We will characterize the role
individual T-cell subsets play in the development of the altered
airway response using adoptive transfer of T cells in nude mice,
analyzing cytokine profiles of these cells and homing responses
following airway challenge. Utilizing IL-5 and IL-4 deficient
mice, we will identify the role of these cytokines in the
development of eosinophilic inflammation. Based on prior studies
of the efficacy of nebulized interferon-gamma to modulate these
antigen-specific responses, we will define how this important
regulatory cytokine alters B and T-cell function to normalize
airway responsiveness following primary or secondary allergen
challenge. These studies will identify the important immunologic
contributions to the acquisition altered airway responsiveness,
paving the way to a better understanding of the pathogenesis of
asthma and the development of novel therapeutic options.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease
-
批准号:8147497
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2010
-
负责人:ERWIN William GELFAND
-
依托单位:
Administrative Core A
-
批准号:8147505
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2010
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:7910663
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
-
批准号:7821778
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
-
批准号:7942064
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:7729164
-
项目类别:
-
资助金额:$45.89万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8310977
-
项目类别:
-
资助金额:$46.83万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8503580
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8085839
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally occurring T regulatory cells control airway hyperresponsiveness
-
批准号:7683378
-
项目类别:
-
资助金额:$48.67万
-
财政年份:2008
-
负责人:ERWIN William GELFAND
-
依托单位:
Administrative Core
-
批准号:7255196
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2007
-
负责人:ERWIN William GELFAND
-
依托单位:
LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease
-
批准号:7255194
-
项目类别:
-
资助金额:$58.24万
-
财政年份:2007
-
负责人:ERWIN William GELFAND
-
依托单位:
ROLE OF T LYMPHOCYTES IN AIRWAY HYPERRESPONSIVENESS
-
批准号:6612395
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2002
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:6390055
-
项目类别:
-
资助金额:$29.41万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:6184904
-
项目类别:
-
资助金额:$28.72万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:7226658
-
项目类别:
-
资助金额:$32.34万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:2858661
-
项目类别:
-
资助金额:$28.01万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:6895611
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:7035277
-
项目类别:
-
资助金额:$33.31万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:6527185
-
项目类别:
-
资助金额:$30.12万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
海外基金